Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model

Author: Nawa A.   Nozawa N.   Goshima F.   Nagasaka T.   Kikkawa F.   Niwa Y.   Nakanishi T.   Kuzuya K.   Nishiyama Y.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.91, Iss.1, 2003-10, pp. : 81-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content